{"text": ["AbbVie", "Is", "Mizuho\u2019s", "Top", "Pick", "Among", "Large-Cap", "Biopharma", "Stocks"], "created_at": "2021-01-07 13:45:00"}
{"text": ["Risankizumab", "(SKYRIZI\u00ae)", "Demonstrates", "Significant", "Improvements", "in", "Clinical", "Remission", "and", "Endoscopic", "Response", "in", "Two", "Phase", "3", "Induction", "Studies", "in", "Patients", "with", "Crohn's", "Disease"], "created_at": "2021-01-07 13:45:00"}
{"text": ["3", "Biotech", "Technological", "Developments", "to", "Watch", "Out", "For", "in", "2021"], "created_at": "2021-01-07 13:42:01"}
